Tresiba FlexTouch

Tresiba is a long-acting basal insulin (insulin degludec) used to improve blood sugar control in adults and children with diabetes mellitus. The FlexTouch delivery device is a pre-filled pen designed for ease of use and consistent dosing.

The brand originated in Denmark under Novo Nordisk, a global healthcare company with nearly a century of innovation in diabetes care. While headquartered in Denmark, the company operates a sprawling global manufacturing network. Depending on the specific market, the pens are manufactured and assembled in facilities located in Denmark, the United States, France, or Brazil. Novo Nordisk remains the ultimate owner and handles global distribution through its various international subsidiaries.